PPD country experts discuss how local government changes are anticipated to cause a steady increase in clinical research across the region and expand its role in the global development of new therapeutic treatments.
Regulatory Rapporteur (October 2019)
PPD is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ increasing research needs.
Richmond Times-Dispatch (September 2019)
Timothy King discusses the rationale, advantages and disadvantages behind strategically selecting the right outsourcing model.
Contract Pharma (September 2019)
Incorporating patient insights into clinical trial design has ‘consistently’ shown to improve timelines.
Outsourcing-Pharma (September 2019)
PM360 asked those with expertise in crafting better experiences for patients key questions about how companies must change to better serve patients.
PM360 (September 2019)
North Carolina CRO has landed a contract with a global biopharmaceutical company with a quickly expanding research portfolio – adding to the firm's prestige in oncology and immunology development.
Triangle Business Journal (August 2019)
Biotech Harbour BioMed has teamed up with CRO PPD to work on creating new oncology and immunology meds.
FierceBiotech (August 2019)
Harbour BioMed (HBM) has selected PPD as its preferred global contract research partner to conduct clinical studies on its internal research pipelines.
WilmingtonBiz (August 2019)
Evidera has entered into an exclusive collaboration agreement with Clinical Study Support, Inc., extending both organizations’ capabilities to deliver more robust consulting and analytical capabilities.
Outsourcing-Pharma (August 2019)
Harbour BioMed (HBM) and PPD have announced a strategic collaboration to develop HBM’s innovative therapeutics in the fields of oncology and immunology.
We want to hear from you
Register in PPD's Database
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.